How leading pharma/device firms employ sustainability

Medical device and pharmaceutical manufacturers recognize that sustainability efforts can pay multiple dividends.

Eco box
Eco box

Downgauging, lightweighting, and using fewer packaging materials are steps manufacturers have taken for years to cut costs where and when possible without compromising product integrity and efficacy. But sustainable business practices dive deeper than at medical device manufacturers and pharmaceutical firms.

In the pharmaceutical and medical device sectors where patient safety and regulatory compliance take precedence, manufacturers are also committing to sustainable practices, not only in material selection, but in facility management, processing, and packaging lines. And many of these manufacturers are counting on their packaging suppliers to be partners in those sustainability efforts.

Says Chris Bagozzi, manager of sterile packaging development for Medtronic Spinal and Biologics, “Medtronic is serious about sustainability. We recognize the critical interdependence between human health and the environment. Our wellbeing ultimately depends on the health and resources of the planet. For this reason, we continually strive to reduce our environmental impact. Environmental stewardship is a key pillar of corporate citizenship and provides Medtronic with a competitive advantage by satisfying our customers, reducing costs, and managing risks. Product packaging has played a major role in the company’s overall sustainability strategy.”

Enacted in Nov. 2007, Medtronic’s Environmental Sustainability Policy involves promoting energy efficiency, conserving natural resources, purchasing sustainable products, eliminating waste, reusing and recycling materials, enhancing new building construction and facility modification, and establishing environmental goals.

Medtronic sets targets

Medtronic’s goal-based sustainable efforts for the next fiscal year include 10% reductions in volatile organic compound air emissions, greenhouse gas emission and water use, and 5% reductions in regulated and nonregulated waste.

“The baseline for these goals is fiscal year 2007,” says Bagozzi. “Innovative new product packaging and literature reduction projects reduced the amount of packaging waste and paper literature by over three million pounds and saved $2.3 million. We have locations [that] have reduced millions of pounds of waste and saved over $20 million. Recently, Medtronic’s Spinal business won a sustainability award for its efforts involving cold chain shipping containers and advancements in traceability. Both efforts resulted in waste reduction.

“The cold chain shipper accomplishment was the result of switching from traditional shipping containers and materials to a more sustainable option. The business yielded a financial savings in excess of $1 million a year. The company reduced the shipper sizes, foam insulation, and the number of gel packs required for the cold chain shipments. This was in part due to collaboration with the marketing and distribution teams in determining the optimal amount of kits per shipment. Previously, the shipper was designed to accommodate space for four kits. It was determined there was a need for various shipper sizes to accommodate smaller shipments; therefore, we created 1-Kit, 2-Kit, and 3-Kit variations of the shipping configuration.”

He gives credit for the project’s success to New-Tech Packaging (www.newtechpackaging.com), which he says made the initial suggestion of using smaller shipper sizes, and also to the Medtronic Spinal packaging engineers (past and present), who contributed to the new shipper and kit designs. In the end, Medtronic was also able to reduce the labor costs, energy requirements, and packaging waste associated with shipping the product,” Bagozzi says.

Janssen/J&J goals

Philip Dahlin, senior manager of sustainability for the Janssen Pharmaceutical Companies of Johnson & Johnson relates that setting and tracking goals are important to his company’s sustainability pursuits. “We started out by focusing on ‘hot-spot’ items like PVC [polyvinyl chloride] and paper sourcing. One of our initial goals was to eliminate all PVC packaging, with the exception of primary packaging for pharmaceuticals, as there was no real viable alternative at the time for PVC blisters.

“The second goal was to ensure sustainable sourcing of fiber materials--all of our paper goods and paperboard. For these materials, we have goals of using 100-percent SFI [Sustainable Forestry Initiative] or FSC [Forest Stewardship Council]-certified content, and/or 30 percent post-consumer content.”
Dahlin says the company’s EARTHWARDS program is meant to guide development teams in all three of its sectors--Pharmaceutical, Consumer Products, and Medical Devices & Diagnostics—in developing greener products, and packaging is part of that. “Each sector designs its own packages,” he explains. “One of the big targets that we’re looking at is replacing petroleum-based polymers with bio-based polymers.”

Commenting on biopolymers, Edward Bauer, a Packaging Hall of Fame inductee, expresses concerns. “Biopolymers do not provide the performance and protection required by the products and fall far short of the requirements set by the FDA to deliver safe, efficacious products in safe packaging. Most of the materials cannot withstand relatively low temperatures and they, almost universally, are poor moisture barriers, which is the primary requirement for protecting most products. The polyalkanoates have the potential to possibly overcome this gap, although they carry for the foreseeable future a tremendous increase in cost when compared to petroleum-based polymers. The question of cost is not insignificant considering the amount of emphasis being placed upon it by the ‘unsustainable’ increase in healthcare costs.”

An anonymous respondent to Healthcare Packaging’s 2012 “Voices of Leadership” questionnaire says her company has developed global environmental packaging guides that incorporate regulations from different customers. “For each product, we calculate the weight and mass of materials going into each market. We also fill out a questionnaire that outlines what the components of each package are, what is the material, how much glue is used , the pre-consumer and post-consumer percentages, how much paper, and how much plastic. We look into each supplier to find out if they meet our requirements for heavy metals, the overall parts per million in components.”

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report